NCT02009592View on ClinicalTrials.gov

Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions
Fatty LiverSteatohepatitis
Interventions
DRUG

Rifaximin

Both arms receive Rifaximin

Trial Locations (1)

34093

Bezmialem Vakif University, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT02009592 - Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients | Biotech Hunter | Biotech Hunter